Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Operating environment is getting tougher

Orora
3:27pm
April 2, 2024
ORA’s trading update was disappointing with group FY24 earnings guidance downgraded. The updated guidance mainly reflected continued volume softness and price deflation in North America (particularly in Distribution) and ongoing customer destocking in Saverglass. Updates to earnings forecasts and slight adjustments to FX assumptions see FY24-26F group EBIT decrease by 9-13% and underlying NPAT decline by 13-18%. Our target price falls to $2.30 (from $2.70) and we maintain our Hold rating. While ORA’s trading metrics are undemanding (13.6x FY25F PE and 4.1% yield), the operating outlook remains weak with the timing of any rebound in demand uncertain. In addition, the performance of Saverglass since acquisition has been underwhelming. We hence maintain our cautious stance until management can show an improvement in the group’s underlying performance.

Gear shift en route to 2027 targets

ALS Limited
3:27pm
April 1, 2024
We update for the Nuvisan, York and Wessling acquisitions and for the slightly softer trading update. We agree with ALQ’s strategic rationale for the acquisitions, we like their complimentary portfolio fit and think they set ALQ up well in the medium term. However they are skewed toward business turnarounds short-term, diluting group margins and bringing integration risk which may take time to digest. We lift our blended valuation/ target to $13.70ps (from $13.35). We rate ALQ very highly but move to Hold as price strength has narrowed capital beneath 10%.

Next phase of asset recycling and capital works

Hotel Property Investments
3:27pm
March 26, 2024
HPI has announced four divestments for $.6m to its major tenant Australian Venue Co. The assets have been sold in line with Dec-23 book values with proceeds to be recycled into development on existing assets within the portfolio (rentalised at 7.5%). HPI has previously successfully undertaken capex programs with AVC (22/61 assets refurbished since 2020) so we expect this next phase to deliver positive benefits to the overall portfolio as well as enhanced rental income. FY24 DPS guidance of 19cps has been reiterated which equates to a distribution yield of 5.8%. We retain an Add rating with a revised price target of $3.71.

Putting its dry powder to work

WH Soul Pattinson & Co
3:27pm
March 25, 2024
SOL released its 1H24 result, which in our view, highlighted a broadly resilient performance of the investment portfolio. Management were active in the period, with ~A$2.4bn worth of transactions being conducted and net investing activity across SOL’s portfolio’s seeing net cash decline by ~A$658m. Key contributions from its core strategic holdings and the Credit portfolio helped grow SOL’s net cash from investments 7% on pcp to ~A$263m. A 40cps fully-franked interim dividend was declared (24 consecutive years of dividend increases). Our DDM/SOTP-derived price target is A$35.60 (from A$34.75). Our changes to forecasts are overleaf. We continue to like the SOL story, particularly its track record of growing distributions and history of uncorrelated and above market returns. We maintain our Add recommendation.

US marketing partner continues to improve

Aroa Biosurgery
3:27pm
March 22, 2024
ARX’s US marketing partner TelaBio reported an in line CY23 result and provided CY24 revenue growth guidance of ~30% which was in line with consensus. This is a positive read through for ARX and gives us confidence that average revenue growth of 20% pa can be achieved for the next three years. No changes to forecast or valuation. Add maintained.

Certainly didn’t waste a crisis

Webjet
3:27pm
March 21, 2024
The key takeaway from the WebBeds Strategy Day is that management is confident of delivering A$10bn of TTV by FY30 via organic means. Importantly, this will be achieved while delivering an industry leading EBITDA margin of 50% and strong cashflow conversion of 90-110%. Whilst we have only made slight upgrades to our forecasts reflecting WEB’s FY30 targets, the potential upgrades for consensus will be much more material. The next update from WEB is likely at its FY24 result on 22 May when we expect it to release its capital management policy given its strong balance sheet. With a double-digit earnings growth profile out to FY30, we maintain an Add rating.

Activity air-pocket, with strong long-run demand

Brickworks
3:27pm
March 21, 2024
BKW continues to paint a relatively sanguine picture, with building products expected to see some short-term weakness. The property portfolio has declined in value as a result of a 100bps increase in cap rates to 5.1%, despite continued strength across the underlying operating markets. Longer term, management remains firmly of the opinion that Australia is on the cusp of a property boom, with record immigration levels and population growth exacerbating an already chronic housing undersupply issue. The industrial portfolio is expected to continue growing rental income, with the business outlining a path to double rent through continued development and passing rental growth. Our view remains largely unchanged, with the short to medium outlook remaining relatively soft, which will see the group strategy shifting from investment to cashflow generation. This sees modest earnings growth through FY25, hence our Hold recommendation.

No surprises ... now a waiting game for ACCC decision

Sigma Healthcare Ltd
3:27pm
March 21, 2024
SIG posted its FY24 result which came in at the top end of EBIT guidance (pre-merger costs of $8.2m). As we expected there was limited commentary around the ACCC process, with SIG making its submission in February and public consultation starting from 8 March. We don’t expect a decision until the end of CY24. Given our view on the timing of the ACCC announcement we have delayed the incorporation of the CWG business into our model by six months. After rolling our model forward and including CWG from 31 January 2025 our target price has increased to $1.14 (was $1.07). As the share price is within 10% of the new target we move to a Hold (previously Add) recommendation.

Growing the Swiss footprint

Sonic Healthcare
3:27pm
March 20, 2024
Sonic Healthcare (SHL) is acquiring Switzerland-based Dr Risch laboratory group (Dr Risch) for CHF117m (A$202m), including CHF30m (A$52m) in scrip, with the balance funded via existing CHF cash and debt. Dr Risch employs c650 staff across 13 laboratories and has a lab in Liechtenstein, with a full-range offering of routine and specialty laboratory testing and combined annual turnover of cCHF102m (cA$176m). The deal is expected to close by 31 Mar-24, with the transaction EPS accretive from CY25 and ROIC positive once synergies from multiple areas of infrastructure and operations are achieved. We have adjusted FY24-26 estimates, with our target price increasing to A$34.94 (from A$34.05). Add rating maintained.

+50% margins through the cyclical low ain’t bad

New Hope Group
3:27pm
March 19, 2024
Another typically solid 1H result from NHC with few surprises outside of the dividend which beat our cautious estimate. All guidance was re-affirmed, with higher volumes to support 2H cost reduction. NHC’s defensive attributes – cash margins, balance sheet, steady dividends – appear to support lower volatility relative to more leveraged peers. Maintain Hold as NHC trades within 10% of fair value. A forecast 7-8% yield offers solid compensation as investors await the next upswing.

News & Insights

Treasury Secretary Scott Bessent’s adept negotiation of a US-China tariff deal and his method for assessing tariffs’ modest impact on inflation, using a 20.5% effective rate, position him as a formidable successor to Henry Morganthau’s legacy.

In the 1930s, the US Treasury Secretary Henry Morganthau was widely regarded as the finest Treasury Secretary since Alexander Hamilton. However, if the current Treasury Secretary Scott Bessent, continues to deliver results as he is doing now, he will provide formidable competition to Morganthau’s legacy.

The quality of Bessent’s work is exceptional, demonstrated by his ability to secure an agreement with China in just a few days in complex circumstances.

The concept of the "effective tariff rate" is a term that has gained traction recently. Although nominal tariff rates on individual goods in individual countries might be as high as 100% or 125%; the effective tariff rate, which reflects the actual tariffs the US imposes on imports from all countries, is thought to be only 20.5%. This figure comes from an online spreadsheet published by Fitch Ratings, since 24 April.

Finch Ratings Calculator Screenshot

This effective tariff rate of 20.5% can be used in assessing the impact of import tariffs on US inflation. To evaluate this, I used a method proposed by Scott Bessent during his Senate confirmation hearing. Bessent began by noting that imports account for only 16% of US goods and services that are consumed in the US Economy. In this case, a 10% revenue tariff would increase domestic prices by just 1.6%. With a core inflation rate of 2.8% in the US, this results in a headline inflation rate of 4.4%. Thus, the overall impact of such tariffs on the US economy is relatively modest.

A couple of weeks ago, Austan Goolsbee, the President of the Chicago Fed, noted that tariffs typically increase inflation, which might prompt the Fed to lift rates, but they also reduce economic output, which might prompt the Fed to rate cuts. Consequently, Goolsbee suggested that the Federal Reserve might opt to do nothing. This prediction was successful when the Open Market Committee of the Fed, with Goolsbee as a member, left the Fed Funds rate unchanged last week.

A 90-day agreement between the US and China, masterfully negotiated by Scott Bessent, has dramatically reduced tariffs between China and the US. China now only imposes a 10% import tariff on the US, while the US applies a 30% tariff on Chinese goods—10% as a revenue tariff and 20% to pressure China to curb the supply of fentanyl ingredients to third parties in Mexico or Canada. It is this fentanyl which fuels the US drug crisis. This is a priority for the Trump administration.

How Import Tariffs Affect US Inflation.

We can calculate how much inflation a tariff adds to the US economy in the same way as Scott Bessent by multiplying the effective tariff rate by the proportion that imports are of US GDP. Based on a 20.5% US effective tariff rate, I calculated that it adds 3.28% to the US headline Consumer Price Index (CPI). This results in a US headline inflation rate of 6.1% for the year ahead. In Australia, we can draw parallels to the 10% GST introduced 24 years ago, where price effects were transient and vanished after a year, avoiding sustained high inflation.

Before these negotiations, the US was levying a nominal tariff on China of 145%. Some items were not taxed, so meant that the effective tariff on China was 103%. Levying this tariff meant that the US faced a price effect of 3.28%, contributing to a 6.1% headline inflation rate.

If the nominal tariff rate dropped to 80%, the best-case scenario I considered previously, the price effect would fall to 2.4%, with a headline US inflation rate of 5.2%. With the US now charging China a 30% tariff, this adds only 2% to headline inflation, yielding a manageable 4.8% US inflation rate.

As Goolsbee indicated, the Fed might consider raising interest rates to counter inflation or cutting them to address reduced output, but ultimately, it is likely to maintain current rates, as it did last week. I anticipate the Fed will continue to hold interest rates steady but with an easing bias, potentially cutting rates in the second half of the year once the situation stabilises.

My current Fed Funds rate model suggests that, absent this year's tariff developments, the Fed would have cut rates by 50 basis points. This could be highly positive for the US economy.

Read more
In a lively presentation to the Economic Club of New York, Federal Reserve Bank of Chicago President Austan Goolsbee highlighted tariffs as a minor stagflation risk but emphasized strong U.S. GDP growth of around 2.6%, suggesting a resilient economy and potential for a soft landing.

I’d like to discuss a presentation delivered by Austan Goolsbee, President of the Federal Reserve Bank of Chicago, to the Economic Club of New York on 10 April. Austan Goolsbee, gave a remarkably animated talk about tariffs and their impact on the U.S. economy.

Goolsbee is a current member of the Federal Reserve’s Open Market Committee, alongside representatives from Washington, D.C., and Fed bank Presidents from Chicago, Boston, St. Louis, and Kansas City.  

Having previously served as Chairman of the Council of Economic Advisers in the Obama White House, Goolsbee’s presentation style in New York was notably different from his more reserved demeanour I had previously seen when I had attended a talk of his in Chicago.

During his hour-long, fast-paced talk, Goolsbee addressed the economic implications of tariffs. He recounted an interview where he argued that raising interest rates was not the appropriate response to tariffs, a stance that led some to label him a “Dove.” He humorously dismissed the bird analogy, instead likening himself to a “Data Dog,” tasked with sniffing out the data to guide decision-making.

Goolsbee explained that tariffs typically drive inflation higher, which might ordinarily prompt rate hikes. However, they also tend to reduce economic growth, suggesting a need to cut rates. This creates a dilemma where rates might not need adjustment at all. He described tariffs as a “stagflation event” but emphasised that their impact is minor compared to the severe stagflation of the 1970s.

When asked if the U.S. was heading towards a recession, Goolsbee said that the "hard data" was surprisingly strong.

Let us now look at our model of US GDP based on the Chicago Fed National Activity Index. This Index   incorporates 85 variables across production, sales, employment, and personal consumption.  In the final quarter of last year, this index indicated the GDP growth was slightly below the long-term average, suggesting a US GDP growth rate of 1.9% to 2%.

However, data from the first quarter of this year showed stronger growth, just fractionally below the long-term trend.

Using Our Chicago Fed model, we find that US GDP growth had risen from about 2% growth to a growth rate of around 2.6%, indicating a robust U.S. economy far from recessionary conditions.

Model of US GDP

We think that   increased government revenue from Tariffs might temper domestic demand, potentially guiding growth down towards 1.9% or 2% by year’s end. Despite concerns about tariffs triggering a downturn, this highlights the economy’s resilience and suggests   a “soft landing,” which could allow interest rates to ease, weaken the U.S. dollar, and boost demand for equities.

We will provide monthly reviews of these indicators. We note that, for now, the outlook for the U.S. economy remains very positive.

Read more
This discussion simplifies the US business cycle, highlighting how tariffs are projected to lower growth to 1.8% in 2025, reduce the budget deficit, and foster an extended soft landing, boosting equities and commodities through 2027.


I want to discuss a simplified explanation of the US business cycle, prompted by the International Monetary Fund's forecast released yesterday, which, for the first time, assessed the impact of tariffs on the US economy. Unlike last year's 2.8% growth, the IMF predicts a drop to 1.8% in 2025. This is slightly below my forecast of 1.9 to 2%. They further anticipate growth will decline to 1.7% in 2026, lower than my previous estimate of 2%. Growth then returns to 2% by 2027.

This suggests that increased tariffs will soften demand, but the mechanism is intriguing. Tariffs are expected to reduce the US budget deficit from about 7% of GDP to around 5%, stabilizing government debt, though more spending cuts are needed.  This reduction in US deficit reduces US GDP growth. This leads to a slow down.

The revenue from tariffs is clearly beneficial for the US budget deficit, but the outlook for the US economy now points to an extended soft landing. This is the best environment for equities and commodities over a two-year view. With below-trend growth this year and even softer growth next year, interest rates are expected to fall, leading the fed funds rate to drift downward in response to slower growth trends. Additionally, the US dollar is likely to weaken as the Fed funds rate declines, following a traditional US trade cycle model: falling interest rates lead to a weaker currency, which in turn boosts commodity prices.

This is particularly significant because the US is a major exporter of agricultural commodities, has rebuilt its oil industry, and is exporting LNG gas. The rising value of these commodities stimulates the economy, boosting corporate profits and setting the stage for the next surge in growth in a couple of years.

This outlook includes weakening US interest rates and rising commodity prices, continuing through the end of next year. This will be combined with corporate tax cuts, likely to be passed in a major bill in July, reducing US corporate taxes from 21% to 15%.  This outlook is very positive for both commodities and equities. Our model of commodity prices shows an upward movement, driven by an increase in international liquidity within the international monetary system.

With US dollar debt as the largest component in International reserves , as US interest rates fall, the creation of US government debt accelerates, increasing demand for commodities.  The recent down cycle in commodities is now transitioning to an extended upcycle through 2026 and 2027, fueled by this increased liquidity due to weaker interest rates.

Furthermore, the rate of growth in international reserves is accelerating, having reached a long-term average of about 7% and soon expected to rise to around 9%. Remarkably, the tariffs are generating a weaker US dollar, which drives the upward movement in commodity prices. This improvement in commodity prices is expected to last for at least the next two years, and potentially up to four years.

Read more